Results 91 to 100 of about 24,021 (224)

Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

open access: yesMuscle &Nerve, Volume 74, Issue 1, Page 59-67, July 2026.
ABSTRACT Introduction/Aims Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder of the nervous system that detrimentally influences health‐related quality of life (HRQoL). Evidence regarding factors influencing HRQoL in CIDP is scarce.
Tobias C. Blum   +7 more
wiley   +1 more source

The frequency of psoriasis in Australian multiple sclerosis patients

open access: yesFrontiers in Neurology
BackgroundMultiple Sclerosis (MS) is an immune-mediated, demyelinating disease of the central nervous system. Although psoriasis and psoriasiform dermatitis are reported in MS patients, the prevalence of the diseases is uncertain globally and unstudied ...
Varitsara Mangkorntongsakul   +14 more
doaj   +1 more source

Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 6, Page 1186-1195, June 2026.
ABSTRACT Objective Kappa free light chains (KFLCs) in the cerebrospinal fluid (CSF) have a similar performance to CSF‐restricted oligoclonal bands (OCB) for multiple sclerosis (MS) diagnosis. To help with implementation, we set out to resolve several remaining uncertainties: (1) performance in a real‐world cohort and the 2024 McDonald criteria; (2 ...
Maya M. Leibowitz   +11 more
wiley   +1 more source

A clear look at the neuroimmunology of multiple sclerosis and beyond

open access: yes, 2012
The term neuroimmunology was first coined to refer to a generic involvement of the immune system in the pathogenesis of neurological diseases, particularly of the central nervous system.
E. Mix   +5 more
core   +1 more source

Possible Anti-Pain Vaccines: A Narrative Review of Emerging Strategies and Clinical Prospects

open access: yesVaccines
Chronic pain affects millions of individuals globally and continues to pose a major burden on patients and healthcare systems. Traditional analgesics, such as opioids and nonsteroidal anti-inflammatory drugs, often provide only partial relief and are ...
Yuri Chaves Martins   +4 more
doaj   +1 more source

Whole‐Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 6, Page 1129-1140, June 2026.
ABSTRACT Objective To characterize whole‐body intramuscular fat distribution pattern in patients with sarcoglycanopathies and explore correlations with disease severity, duration and age at onset. Methods Retrospective, cross‐sectional, multicentric study enrolling patients with variants in one of the four sarcoglycan genes who underwent whole‐body ...
Laura Costa‐Comellas   +39 more
wiley   +1 more source

Uveitis in patients with multiple sclerosis

open access: yes, 2012
11th International Congress of Neuroimmunology (ISNI) -- NOV 04-08, 2012 -- Boston, MAWOS: 000312764800091…European Sch Neuroimmunol, Int Soc Neuroimmunol ...
Kurtuncu, Murat   +6 more
core  

The interaction of neuroimmunology, neuromodulator, and neurotransmitter with nociceptor and MAPK signaling

open access: yesBali Journal of Anesthesiology, 2019
Physiological pain is a protection mechanism against tissue damage or potential tissue damage. Inflammation pain is followed by tissue damage due to temperature, mechanical and chemical stimuli which increase crosstalk between neuron nociceptor, immune ...
Dewa Ayu Mas Shintya Dewi, Made Wiryana
doaj   +1 more source

Switch-associated protein 70 (SWAP 70) antibody levels are associated with clinical relapse in multiple sclerosis

open access: yes, 2012
11th International Congress of Neuroimmunology (ISNI) -- NOV 04-08, 2012 -- Boston, MAWOS: 000312764800046…European Sch Neuroimmunol, Int Soc Neuroimmunol ...
Vural, Burcak   +6 more
core  

Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)

open access: yesAlzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract Since 2016, the Alzheimer's Association and the Fondation Alzheimer have hosted Global Alzheimer's Leadership Series (GoALS) global think tanks, with world‐leading experts for innovative discussions to advance Alzheimer's disease (AD) research and care.
Philippe Amouyel   +26 more
wiley   +1 more source

Home - About - Disclaimer - Privacy